Skip to Main content Skip to Navigation
Journal articles

Complement cascade in severe forms of COVID-19: Recent advances in therapy

Abstract : The complement system is an essential component of the innate immune system. The three complement pathways (classical, lectin, alternative) are directly or indirectly activated by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). In the most severe forms of COVID-19, overactivation of the complement system may contribute to the cytokine storm, endothelial inflammation (endotheliitis) and thrombosis. No antiviral drug has yet been shown to be effective in COVID-19. Therefore, immunotherapies represent a promising therapeutic in the immunopathological phase (following the viral phase) of the disease. Complement blockade, mostly C5a-C5aR axis blockade, may prevent acute respiratory distress syndrome (ARDS) from worsening or progression to death. Clinical trials are underway.
Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03226299
Contributor : Julien Caugant Connect in order to contact the contributor
Submitted on : Friday, May 14, 2021 - 1:31:07 PM
Last modification on : Tuesday, October 19, 2021 - 10:59:27 PM
Long-term archiving on: : Sunday, August 15, 2021 - 6:17:04 PM

File

eji.202048959.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Nassima Chouaki Benmansour, Julien Carvelli, Eric Vivier. Complement cascade in severe forms of COVID-19: Recent advances in therapy. European Journal of Immunology, Wiley-VCH Verlag, 2021, pp.1-8. ⟨10.1002/eji.202048959⟩. ⟨hal-03226299⟩

Share

Metrics

Record views

137

Files downloads

31